Skip to main content
VNDA logo

VNDA · Vanda Pharmaceuticals Inc.

$4.96 -0.20 (-3.88%)
Market Cap
$310.30M
Shares
60.14M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-03-02 Gunther Birznieks 42,431
2026-03-02 Joakim Wijkstrom 30,800
2026-03-02 Kevin Moran 42,442
2026-03-02 Mihael H. Polymeropoulos 156,235
2026-03-02 Timothy Williams 42,434
2026-02-23 Honore Tage 30,000
2025-06-13 Mitchell Stephen Ray 7,000
2024-11-14 Mitchell Stephen Ray 5,000
2024-07-29 Moran Kevin Patrick 2,251
2024-03-04 Wijkstrom Joakim 30,300
2024-03-04 Polymeropoulos Mihael Hristos 101,250
2024-03-04 Moran Kevin Patrick 27,689
2024-03-04 Williams Timothy 32,025
2024-03-04 Birznieks Gunther 32,025
2023-08-21 Wijkstrom Joakim 3,724
2023-08-10 Mitchell Stephen Ray 6,500
2023-07-28 Moran Kevin Patrick 2,212
2023-06-15 Moran Kevin Patrick 16,000
2023-06-13 Williams Timothy 14,600
Showing 1–19 of 19 filings
Key facts CIK 1347178 CUSIP 921659108 13F (30d) 28 filings 28 filers Visit website Investor relations